Free · no account · about 20 seconds

    Check your fit ›

    Funds health research and innovation: diagnostics, therapeutics, digital health, medical technology and public-health tools.

    Open calls, soonest deadline first

    European Partnership on Rare Diseases (ERDERA) (Phase 2)HORIZON-HLTH-2026-02-DISEASE-12Addressing disabilities through the life course to support independent living and inclusionHORIZON-HLTH-2027-01-STAYHLTH-01 · Opens 10 Feb 2027Prevention and management of chronic non-communicable diseases in children and young people (GACD)HORIZON-HLTH-2027-01-DISEASE-10 · Opens 10 Feb 2027Tools and technologies to support health adaptation to climate changeHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 · Opens 10 Feb 2027European Partnership for Pandemic Preparedness (Phase 2)HORIZON-HLTH-2026-03-DISEASE-13 · Opens 10 Feb 2027Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-07 · Opens 10 Feb 2027Development of cell-free protein synthesis platforms for discovery and/or production of biologicalsHORIZON-HLTH-2027-01-IND-01 · Opens 10 Feb 2027Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-05 · Opens 10 Feb 2027Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-DISEASE-08 · Opens 10 Feb 2027Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-ENVHLTH-02 · Opens 10 Feb 2027Clinical trials for advancing innovative interventions for neurodegenerative diseasesHORIZON-HLTH-2027-02-DISEASE-14-two-stage · Opens 10 Feb 2027Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-06 · Opens 10 Feb 2027Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-01-CARE-02 · Opens 10 Feb 2027Innovative healthcare interventions for non-communicable diseasesHORIZON-HLTH-2027-02-DISEASE-01-two-stage · Opens 10 Feb 2027Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesHORIZON-HLTH-2027-02-TOOL-01-two-stage · Opens 10 Feb 2027Portable and versatile Point-of-care diagnosticsHORIZON-HLTH-2027-02-IND-02-two-stage · Opens 10 Feb 2027Advancing bio-printing of living cells for regenerative medicineHORIZON-HLTH-2027-03-TOOL-02 · Opens 3 Jun 2027Towards Artificial General Intelligence (AGI) for healthcareHORIZON-HLTH-2027-03-TOOL-08 · Opens 3 Jun 2027Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosisHORIZON-HLTH-2027-03-TOOL-04 · Opens 3 Jun 2027

    Questions founders ask about the Horizon Europe health cluster

    When is the next deadline under the Horizon Europe health cluster?

    15 Sep 2026, for European Partnership on Rare Diseases (ERDERA) (Phase 2).

    Can a single company apply to the Horizon Europe health cluster, or is a consortium required?

    19 of the 19 open calls under the Horizon Europe health cluster require a consortium.

    How much does the Horizon Europe health cluster award per project?

    The largest call open now awards €91.3M.

    Other programmes and countries

    Horizon EuropeEuropean Innovation Council (EIC)European Institute of Innovation and Technology (EIT)Horizon Europe Cluster 4 — Digital, Industry and SpaceHorizon Europe Cluster 5 — Climate, Energy and MobilityHorizon Europe Cluster 6 — Food, Bioeconomy and EnvironmentHorizon Europe Cluster 3 — Civil Security for SocietyHorizon Europe — EU MissionsDigital Europe ProgrammeLIFE ProgrammeEuropean Defence FundEurostarsItalyThe United KingdomThe NetherlandsPortugalSwedenFranceGermanySpainBelgiumIrelandFinland